| NDC Code: |
0904-6291 |
| Proprietary Name: |
ATORVASTATIN CALCIUM |
| Suffix: |
|
| Non-Proprietary Name: |
ATORVASTATIN CALCIUM |
| Dosage Form: |
TABLET, FILM COATED |
| Method: |
ORAL |
| Original Marketing Date: |
29-05-2012 |
| Category Name: |
ANDA |
| Application Number: |
ANDA090548 |
| Labeler: |
MAJOR PHARMACEUTICALS |
| Substance Name: |
ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE |
| Active Numerator Strength: |
20 |
| Active Ingredient Unit: |
mg/1 |
| Pharm Classes: |
HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
| DEA Schedule: |
|
